Dr Anne Langsted, University of Copenhagen, Denmark, presents genetic and observational research investigating whether low levels of Lp(a) are associated with increased risk of cancer, infectious diseases, mental disorders, and diabetes.
Novartis has provided with arm’s length sponsorship towards the set-up of the Lp(a) Forum. The content was developed independently by the Forum.